Literature DB >> 31217327

Allosteric, transcriptional and post-translational control of mitochondrial energy metabolism.

Qutuba G Karwi1,2, Alice R Jörg1, Gary D Lopaschuk3.   

Abstract

The heart is the organ with highest energy turnover rate (per unit weight) in our body. The heart relies on its flexible and powerful catabolic capacity to continuously generate large amounts of ATP utilizing many energy substrates including fatty acids, carbohydrates (glucose and lactate), ketones and amino acids. The normal health mainly utilizes fatty acids (40-60%) and glucose (20-40%) for ATP production while ketones and amino acids have a minor contribution (10-15% and 1-2%, respectively). Mitochondrial oxidative phosphorylation is the major contributor to cardiac energy production (95%) while cytosolic glycolysis has a marginal contribution (5%). The heart can dramatically and swiftly switch between energy-producing pathways and/or alter the share from each of the energy substrates based on cardiac workload, availability of each energy substrate and neuronal and hormonal activity. The heart is equipped with a highly sophisticated and powerful mitochondrial machinery which synchronizes cardiac energy production from different substrates and orchestrates the rate of ATP production to accommodate its contractility demands. This review discusses mitochondrial cardiac energy metabolism and how it is regulated. This includes a discussion on the allosteric control of cardiac energy metabolism by short-chain coenzyme A esters, including malonyl CoA and its effect on cardiac metabolic preference. We also discuss the transcriptional level of energy regulation and its role in the maturation of cardiac metabolism after birth and cardiac adaptability for different metabolic conditions and energy demands. The role post-translational modifications, namely phosphorylation, acetylation, malonylation, succinylation and glutarylation, play in regulating mitochondrial energy metabolism is also discussed.
© 2019 The Author(s). Published by Portland Press Limited on behalf of the Biochemical Society.

Entities:  

Keywords:  acetylation; fatty acid oxidation; glucose oxidation; malonyl CoA; malonylation; succinylation

Mesh:

Substances:

Year:  2019        PMID: 31217327     DOI: 10.1042/BCJ20180617

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  7 in total

1.  Puerarin Attenuates LPS-Induced Inflammatory Responses and Oxidative Stress Injury in Human Umbilical Vein Endothelial Cells through Mitochondrial Quality Control.

Authors:  Xing Chang; Tian Zhang; Dong Liu; Qingyan Meng; Peizheng Yan; Duosheng Luo; Xue Wang; XiuTeng Zhou
Journal:  Oxid Med Cell Longev       Date:  2021-02-27       Impact factor: 6.543

2.  Branched-Chain Amino Acid Metabolism in the Failing Heart.

Authors:  Qutuba G Karwi; Gary D Lopaschuk
Journal:  Cardiovasc Drugs Ther       Date:  2022-02-12       Impact factor: 3.727

3.  Application and Prospect of Platelet Multi-Omics Technology in Study of Blood Stasis Syndrome.

Authors:  Ying Li; Ming-Qian Sun; Lei Li; Ye-Hao Zhang; Lan Miao; Jian-Xun Liu
Journal:  Chin J Integr Med       Date:  2021-12-20       Impact factor: 1.978

4.  Delayed Impact of 2-Oxoadipate Dehydrogenase Inhibition on the Rat Brain Metabolism Is Linked to Protein Glutarylation.

Authors:  Alexandra I Boyko; Irina S Karlina; Lev G Zavileyskiy; Vasily A Aleshin; Artem V Artiukhov; Thilo Kaehne; Alexander L Ksenofontov; Sergey I Ryabov; Anastasia V Graf; Angela Tramonti; Victoria I Bunik
Journal:  Front Med (Lausanne)       Date:  2022-06-01

5.  10-Hydroxydec-2-Enoic Acid Reduces Hydroxyl Free Radical-Induced Damage to Vascular Smooth Muscle Cells by Rescuing Protein and Energy Metabolism.

Authors:  Pei Fan; Fangfang Sha; Chuan Ma; Qiaohong Wei; Yaqi Zhou; Jing Shi; Jiaojiao Fu; Lu Zhang; Bin Han; Jianke Li
Journal:  Front Nutr       Date:  2022-05-26

Review 6.  The Contribution of Cardiac Fatty Acid Oxidation to Diabetic Cardiomyopathy Severity.

Authors:  Qutuba G Karwi; Qiuyu Sun; Gary D Lopaschuk
Journal:  Cells       Date:  2021-11-21       Impact factor: 6.600

Review 7.  Dyslipidemia in Kidney Disorders: Perspectives on Mitochondria Homeostasis and Therapeutic Opportunities.

Authors:  Pei-Hui Lin; Pu Duann
Journal:  Front Physiol       Date:  2020-09-03       Impact factor: 4.566

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.